LSTA FY 2020 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$63,000

Operating Income

-$19M

Net Income

-$8M

EPS (Diluted)

$-7.91

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$36M

Total Liabilities

$4M

Stockholders' Equity

$32M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$63,000	-$65,000	+3.1%
Operating Income	-$19M	-$20M	+4.7%
Net Income	-$8M	-$20M	+59.5%